Studies on the Oral Anticancer Drug JM-216:  Synthesis and Characterization of Isomers and Related Complexes

Studies on the Oral Anticancer Drug JM-216:  Synthesis and Characterization of Isomers and Related Complexes

The complex cis,trans,cis-[PtCl2(OAc)2NH3(c-C6H11NH2)] (JM-216) is currently undergoing clinical evaluation as an antitumor agent. In support of characterization and analysis of this complex a study of its isomers and other complexes [PtCl m (OAc)(4 - m )NH3(c-C6H11NH2)] (m = 0−4) has been undertake...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inorganic chemistry 1996-05, Vol.35 (11), p.3280-3284
Hauptverfasser: Barnard, Christopher F. J, Vollano, Jean F, Chaloner, Penny A, Dewa, Shaliza Z
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3284
container_issue 11
container_start_page 3280
container_title Inorganic chemistry
container_volume 35
creator Barnard, Christopher F. J
Vollano, Jean F
Chaloner, Penny A
Dewa, Shaliza Z
description The complex cis,trans,cis-[PtCl2(OAc)2NH3(c-C6H11NH2)] (JM-216) is currently undergoing clinical evaluation as an antitumor agent. In support of characterization and analysis of this complex a study of its isomers and other complexes [PtCl m (OAc)(4 - m )NH3(c-C6H11NH2)] (m = 0−4) has been undertaken. The complexes have been obtained by a variety of synthetic routes which now extend the scope for the preparation of platinum(IV) antitumor complexes. As platinum(IV) complexes are very stable to substitution in the absence of catalysis, use has been made of both light and base catalysis to promote substitution. Oxidative addition to platinum(II) using hypervalent iodine reagents has also been used. The stereochemistry of the complexes has been confirmed by spectroscopic studies, primarily NMR including natural abundance 15N NMR spectroscopy.
doi_str_mv 10.1021/ic951548n
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859358356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859358356</sourcerecordid><originalsourceid>FETCH-LOGICAL-a417t-bc780e3a4bc620cae82607bcaf29b87493ca6d0ea523ed456727a56d6dcc72063</originalsourceid><addsrcrecordid>eNpt0Mtu1DAUBmALUdGhsOAFkDdIsEjrS2wn7KqB3lQoYgpiZ504Z2hK4gy2I7Ws2PKaPEldZVQ2rHzk8-k_0k_IC872ORP8oHO14qqs_COy4EqwQnH27TFZMJZnrnW9S57GeM0Yq2Wpn5Bdnj-1EvWC-FWa2g4jHT1NV0gvAvT00KfOgXcY6LswfadnHwrB9du_v__Q1a3PLHaRgm_p8goCuISh-wWpyxHjmp7GccAw7z9jDwmzG4dNjzcYn5GdNfQRn2_fPfLl6P3l8qQ4vzg-XR6eF1Byk4rGmYqhhLJxWjAHWAnNTONgLeqmMmUtHeiWISghsS2VNsKA0q1unTOCablHXs-5mzD-nDAmO3TRYd-Dx3GKlleqlqqS6p6-makLY4wB13YTugHCreXM3tdrH-rN9uU2dmoGbP_JbZ8ZFDPoYsKbhz2EH1YbaZS9_LSyH8vjs69ydWRPsn81e3DRXo9T8LmV_xy-A1QWkQY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1859358356</pqid></control><display><type>article</type><title>Studies on the Oral Anticancer Drug JM-216:  Synthesis and Characterization of Isomers and Related Complexes</title><source>American Chemical Society Journals</source><creator>Barnard, Christopher F. J ; Vollano, Jean F ; Chaloner, Penny A ; Dewa, Shaliza Z</creator><creatorcontrib>Barnard, Christopher F. J ; Vollano, Jean F ; Chaloner, Penny A ; Dewa, Shaliza Z</creatorcontrib><description>The complex cis,trans,cis-[PtCl2(OAc)2NH3(c-C6H11NH2)] (JM-216) is currently undergoing clinical evaluation as an antitumor agent. In support of characterization and analysis of this complex a study of its isomers and other complexes [PtCl m (OAc)(4 - m )NH3(c-C6H11NH2)] (m = 0−4) has been undertaken. The complexes have been obtained by a variety of synthetic routes which now extend the scope for the preparation of platinum(IV) antitumor complexes. As platinum(IV) complexes are very stable to substitution in the absence of catalysis, use has been made of both light and base catalysis to promote substitution. Oxidative addition to platinum(II) using hypervalent iodine reagents has also been used. The stereochemistry of the complexes has been confirmed by spectroscopic studies, primarily NMR including natural abundance 15N NMR spectroscopy.</description><identifier>ISSN: 0020-1669</identifier><identifier>EISSN: 1520-510X</identifier><identifier>DOI: 10.1021/ic951548n</identifier><identifier>PMID: 11666529</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Inorganic chemistry, 1996-05, Vol.35 (11), p.3280-3284</ispartof><rights>Copyright © 1996 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a417t-bc780e3a4bc620cae82607bcaf29b87493ca6d0ea523ed456727a56d6dcc72063</citedby><cites>FETCH-LOGICAL-a417t-bc780e3a4bc620cae82607bcaf29b87493ca6d0ea523ed456727a56d6dcc72063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/ic951548n$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/ic951548n$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11666529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barnard, Christopher F. J</creatorcontrib><creatorcontrib>Vollano, Jean F</creatorcontrib><creatorcontrib>Chaloner, Penny A</creatorcontrib><creatorcontrib>Dewa, Shaliza Z</creatorcontrib><title>Studies on the Oral Anticancer Drug JM-216:  Synthesis and Characterization of Isomers and Related Complexes</title><title>Inorganic chemistry</title><addtitle>Inorg. Chem</addtitle><description>The complex cis,trans,cis-[PtCl2(OAc)2NH3(c-C6H11NH2)] (JM-216) is currently undergoing clinical evaluation as an antitumor agent. In support of characterization and analysis of this complex a study of its isomers and other complexes [PtCl m (OAc)(4 - m )NH3(c-C6H11NH2)] (m = 0−4) has been undertaken. The complexes have been obtained by a variety of synthetic routes which now extend the scope for the preparation of platinum(IV) antitumor complexes. As platinum(IV) complexes are very stable to substitution in the absence of catalysis, use has been made of both light and base catalysis to promote substitution. Oxidative addition to platinum(II) using hypervalent iodine reagents has also been used. The stereochemistry of the complexes has been confirmed by spectroscopic studies, primarily NMR including natural abundance 15N NMR spectroscopy.</description><issn>0020-1669</issn><issn>1520-510X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNpt0Mtu1DAUBmALUdGhsOAFkDdIsEjrS2wn7KqB3lQoYgpiZ504Z2hK4gy2I7Ws2PKaPEldZVQ2rHzk8-k_0k_IC872ORP8oHO14qqs_COy4EqwQnH27TFZMJZnrnW9S57GeM0Yq2Wpn5Bdnj-1EvWC-FWa2g4jHT1NV0gvAvT00KfOgXcY6LswfadnHwrB9du_v__Q1a3PLHaRgm_p8goCuISh-wWpyxHjmp7GccAw7z9jDwmzG4dNjzcYn5GdNfQRn2_fPfLl6P3l8qQ4vzg-XR6eF1Byk4rGmYqhhLJxWjAHWAnNTONgLeqmMmUtHeiWISghsS2VNsKA0q1unTOCablHXs-5mzD-nDAmO3TRYd-Dx3GKlleqlqqS6p6-makLY4wB13YTugHCreXM3tdrH-rN9uU2dmoGbP_JbZ8ZFDPoYsKbhz2EH1YbaZS9_LSyH8vjs69ydWRPsn81e3DRXo9T8LmV_xy-A1QWkQY</recordid><startdate>19960522</startdate><enddate>19960522</enddate><creator>Barnard, Christopher F. J</creator><creator>Vollano, Jean F</creator><creator>Chaloner, Penny A</creator><creator>Dewa, Shaliza Z</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960522</creationdate><title>Studies on the Oral Anticancer Drug JM-216:  Synthesis and Characterization of Isomers and Related Complexes</title><author>Barnard, Christopher F. J ; Vollano, Jean F ; Chaloner, Penny A ; Dewa, Shaliza Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a417t-bc780e3a4bc620cae82607bcaf29b87493ca6d0ea523ed456727a56d6dcc72063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barnard, Christopher F. J</creatorcontrib><creatorcontrib>Vollano, Jean F</creatorcontrib><creatorcontrib>Chaloner, Penny A</creatorcontrib><creatorcontrib>Dewa, Shaliza Z</creatorcontrib><collection>Istex</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Inorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barnard, Christopher F. J</au><au>Vollano, Jean F</au><au>Chaloner, Penny A</au><au>Dewa, Shaliza Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Studies on the Oral Anticancer Drug JM-216:  Synthesis and Characterization of Isomers and Related Complexes</atitle><jtitle>Inorganic chemistry</jtitle><addtitle>Inorg. Chem</addtitle><date>1996-05-22</date><risdate>1996</risdate><volume>35</volume><issue>11</issue><spage>3280</spage><epage>3284</epage><pages>3280-3284</pages><issn>0020-1669</issn><eissn>1520-510X</eissn><abstract>The complex cis,trans,cis-[PtCl2(OAc)2NH3(c-C6H11NH2)] (JM-216) is currently undergoing clinical evaluation as an antitumor agent. In support of characterization and analysis of this complex a study of its isomers and other complexes [PtCl m (OAc)(4 - m )NH3(c-C6H11NH2)] (m = 0−4) has been undertaken. The complexes have been obtained by a variety of synthetic routes which now extend the scope for the preparation of platinum(IV) antitumor complexes. As platinum(IV) complexes are very stable to substitution in the absence of catalysis, use has been made of both light and base catalysis to promote substitution. Oxidative addition to platinum(II) using hypervalent iodine reagents has also been used. The stereochemistry of the complexes has been confirmed by spectroscopic studies, primarily NMR including natural abundance 15N NMR spectroscopy.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>11666529</pmid><doi>10.1021/ic951548n</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-1669
ispartof Inorganic chemistry, 1996-05, Vol.35 (11), p.3280-3284
issn 0020-1669
1520-510X
language eng
recordid cdi_proquest_miscellaneous_1859358356
source American Chemical Society Journals
title Studies on the Oral Anticancer Drug JM-216:  Synthesis and Characterization of Isomers and Related Complexes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A05%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Studies%20on%20the%20Oral%20Anticancer%20Drug%20JM-216:%E2%80%89%20Synthesis%20and%20Characterization%20of%20Isomers%20and%20Related%20Complexes&rft.jtitle=Inorganic%20chemistry&rft.au=Barnard,%20Christopher%20F.%20J&rft.date=1996-05-22&rft.volume=35&rft.issue=11&rft.spage=3280&rft.epage=3284&rft.pages=3280-3284&rft.issn=0020-1669&rft.eissn=1520-510X&rft_id=info:doi/10.1021/ic951548n&rft_dat=%3Cproquest_cross%3E1859358356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1859358356&rft_id=info:pmid/11666529&rfr_iscdi=true